Epilepsy Research
Volume 21, Issue 3 , Pages 195-204, July 1995

An in vitro model of persistent epileptiform activity in neocortex

  • Vivian Valenzuela

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: (718) 270-1356; Fax: (718) 2703840.
    • Department of Neurology, State University of New York Health Science Center, 450 Clarkson Ave., Box 118, Brooklyn, NY 11203, USA
  • ,
  • Larry S. Benardo

      Affiliations

    • Department of Neurology, State University of New York Health Science Center, 450 Clarkson Ave., Box 118, Brooklyn, NY 11203, USA
    • Department of Pharmacology, State University of New York Health Science Center, 450 Clarkson Ave., Brooklyn, NY 11203, USA

Received 26 October 1994; accepted 20 March 1995.

Abstract 

An in vitro model of persistent epileptiform activity was developed to study the mechanisms involved in epileptogenesis. Extracellular recordings were obtained from rat neocortical slices exposed to magnesium-free solution for 2 h. During exposure to magnesium-free solution spontaneous epileptiform activity consisting of interictal bursting and ictal-like discharges were observed. Interestingly, this activity persisted for hours after the slices were returned to magnesium-containing control solution. The N-methyl-d-aspartate (NMDA) receptor antagonist CPP prevented the development of the epileptiform activity, while the non-NMDA receptor antagonist CNQX abolished the epileptiform discharge that persisted aftslices were returned to control solution. These findings suggest there are two distinct phases in the development of epileptic activity in this model, namely, induction (mediated by NMDA receptor activity) and maintenance (supported largely by non-NMDA receptor activity). The similarities and possible parallels between the mechanisms underlying this epileptogenesis and other forms of use-dependent modification of synaptic excitation, such as long-term potentiation, are discussed. This in vitro model of neocortical epileptogenesis may provide insights into the events underlying the development of clinical partial epilepsy.

Keywords:  AMPA/kainate, Experimental epilepsy, Glutamate, N-Methyl-d-aspartate, Neocortex

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: 0920-1211(95)00024-5

Epilepsy Research
Volume 21, Issue 3 , Pages 195-204, July 1995